Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling. [electronic resource]
Producer: 20090319Description: 255-65 p. digitalISSN:- 1541-7786
- Angiogenesis Inhibitors -- pharmacology
- Angiostatic Proteins -- pharmacology
- Cell Movement
- Cells, Cultured
- Endothelium, Vascular -- cytology
- ErbB Receptors -- genetics
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Fibronectins -- pharmacology
- GTP-Binding Protein alpha Subunits, Gi-Go -- metabolism
- Humans
- Immunoblotting
- Immunoprecipitation
- Lysophospholipids -- antagonists & inhibitors
- Microcirculation -- physiology
- Peptide Fragments -- pharmacology
- Phosphatidylinositol 3-Kinases -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Receptors, G-Protein-Coupled -- metabolism
- Receptors, Vascular Endothelial Growth Factor -- genetics
- S Phase -- drug effects
- Signal Transduction -- drug effects
- Skin -- blood supply
- rho-Associated Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.